Application 125147
- Type
- BLA
- Sponsor
- AMGEN
Purple Book Biologic Products#
| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|---|---|---|---|---|
| 125147 | Vectibix | panitumumab | 351(a) | Rx | 2026-09-01 |
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | VECTIBIX | PANITUMUMAB | INJECTABLE; IV (INFUSION) | 5ML/100MG | No | No |
| 002 | VECTIBIX | PANITUMUMAB | INJECTABLE; IV (INFUSION) | 10ML/200MG | No | No |
| 003 | VECTIBIX | PANITUMUMAB | INJECTABLE; IV (INFUSION) | 20ML/400MG | No | No |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Vectibix | PANITUMUMAB | Amgen, Inc | e0fa4bca-f245-4d92-ae29-b0c630a315c2 | 2026-06-23 | Boxed warning, Warnings, Adverse reactions | BLA125147 55513-956 55513-954 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 55513-954 | Vectibix | panitumumab | Amgen Inc | BLA | Current |
| 55513-954 | Vectibix | panitumumab | Amgen Inc | BLA | Current |
| 55513-954 | Vectibix | panitumumab | Amgen Inc | BLA | Current |
| 55513-954 | Vectibix | panitumumab | Amgen Inc | BLA | Current |
| 55513-956 | Vectibix | panitumumab | Amgen Inc | BLA | Current |
| 55513-956 | Vectibix | panitumumab | Amgen Inc | BLA | Current |
| 55513-956 | Vectibix | panitumumab | Amgen Inc | BLA | Current |
| 55513-956 | Vectibix | panitumumab | Amgen Inc | BLA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 80867 | SUPPL | 2025-01-17 |
| 80860 | SUPPL | 2025-01-17 |
| 68498 | SUPPL | 2021-08-31 |
| 68475 | SUPPL | 2021-08-27 |
| 48899 | SUPPL | 2017-07-05 |
| 48873 | SUPPL | 2017-06-30 |
| 18803 | SUPPL | 2015-03-12 |
| 9624 | SUPPL | 2015-03-12 |
| 39860 | SUPPL | 2014-09-03 |
| 31847 | SUPPL | 2014-09-03 |
| 39859 | SUPPL | 2014-05-28 |
| 39857 | SUPPL | 2014-05-28 |
| 9623 | SUPPL | 2014-05-27 |
| 9620 | SUPPL | 2014-05-27 |
| 39858 | SUPPL | 2013-04-01 |
| 9622 | SUPPL | 2013-04-01 |
| 9621 | SUPPL | 2012-08-27 |
| 31846 | SUPPL | 2012-08-21 |
| 18802 | SUPPL | 2012-08-20 |
| 39856 | SUPPL | 2009-07-21 |
| 9619 | SUPPL | 2009-05-08 |
| 39855 | SUPPL | 2009-05-07 |
| 18801 | SUPPL | 2008-07-14 |
| 9618 | SUPPL | 2008-07-08 |
| 39854 | SUPPL | 2007-12-03 |
| 31845 | SUPPL | 2007-11-19 |
| 22789 | ORIG | 2006-11-30 |
| 31844 | ORIG | 2006-10-02 |
| 18800 | ORIG | 2006-09-28 |